Inflammatory Bowel Diseases · 2012 · 240 citations · 20 references
Life SciencesGeneticsImmunologyImmunogeneticsImmunopathologyMedical GeneticsCytokine Gene PolymorphismGastrointestinal ImmunologyGenome-wide Association StudiesImmunogenomicsInflammatory Bowel DiseaseInterleukin Gene VariantsIndependent Cohort ValidationInflammatory Bowel Disease GeneticsInflammatory Bowel Disease ImmunopathogenesisInflammatory Bowel Disease PathophysiologyInterleukin-10 Gene VariantsPediatric Ulcerative ColitisSplice-site MutationsVery Early Onset Inflammatory Bowel Disease
BACKGROUND: Interleukin-10 (IL-10) signaling genes are attractive inflammatory bowel disease (IBD) candidate genes as IL-10 restricts intestinal inflammation, IL-10 polymorphisms have been associated with IBD in genome-wide association studies, and mutations in IL-10 and IL-10 receptor (IL-10R) genes have been reported in immunodeficient children with severe infantile-onset IBD. Our objective was to determine if IL-10R polymorphisms were associated with early-onset IBD (EO-IBD) and very-early-onset IBD (VEO-IBD). METHODS: Candidate-gene analysis of IL10RA and IL10RB was performed after initial sequencing of an infantile onset-IBD patient identified a novel homozygous mutation. The discovery cohort included 188 EO-IBD subjects and 188 healthy subjects. Polymorphisms associated with IBD in the discovery cohort were genotyped in an independent validation cohort of 422 EO-IBD subjects and 480 healthy subjects. RESULTS: We identified a homozygous, splice-site point mutation in IL10RA in an infantile-onset IBD patient causing a premature stop codon (P206X) and IL-10 insensitivity. IL10RA and IL10RB sequencing in the discovery cohort identified five IL10RA polymorphisms associated with ulcerative colitis (UC) and two IL10RB polymorphisms associated with Crohn's disease (CD). Of these polymorphisms, two IL10RA single nucleotide polymorphisms, rs2228054 and rs2228055, were associated with VEO-UC in the discovery cohort and replicated in an independent validation cohort (odds ratio [OR] 3.08, combined P = 2 x 10(-4); and OR 2.93, P = 6 x 10(-4), respectively). CONCLUSIONS: We identified IL10RA polymorphisms that confer risk for developing VEO-UC. Additionally, we identified the first splice site mutation in IL10RA resulting in infantile-onset IBD. This study expands the phenotype of IL10RA polymorphisms to include both severe arthritis and VEO-UC.
20
Interleukin-10-deficient mice develop chronic enterocolitis
Ralf Kühn, Jürgen Löhler, D Rennick et al. · Cell · 1993 · 4.3K citations
Mark S. Silverberg, Jack Satsangi, Tariq Ahmad et al. · Canadian Journal of Gastroenterology · 2005 · 3.4K citations · Full text
Predicting Deleterious Amino Acid Substitutions
Pauline C. Ng, Steven Henikoff · Genome Research · 2001 · 2.7K citations · Full text
Pediatric modification of the Montreal classification for inflammatory bowel disease
Arie Levine, Anne M. Griffiths, James Markowitz et al. · Inflammatory Bowel Diseases · 2010 · 1.5K citations · Full text
Medicine, Child Health, Pediatrics +14